Patent details
EP2376533 Title: ANTIBODY FORMULATION
Basic Information
- Publication number:
- EP2376533
- PCT Application Number:
- PCT/EP/2009/066675
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP097648588
- PCT Publication Number:
- WO/2010/066762
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ANTIBODY FORMULATION
- French Title of Invention:
- FORMULATION D'ANTICORPS
- German Title of Invention:
- ANTIKÖRPERFORMULIERUNG
- SPC Number:
Dates
- Filing date:
- 09/12/2009
- Grant date:
- 30/03/2016
- EP Publication Date:
- 30/03/2016
- PCT Publication Date:
- 17/06/2010
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 19/10/2011
- EP B1 Publication Date:
- 30/03/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 09/12/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 09/12/2009
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- WALLNY Hans-Joachim
- Address:
- Switzerland (CH)
2
- Name:
- MOMM Joachim
- Address:
- Switzerland (CH)
Priority
- Priority Number:
- 08170884
- Priority Date:
- 10/12/2008
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- Main IPC Class:
- C07K 16/24;
Annual Fees
- Annual Fee Due Date:
- 31/12/2026
- Annual Fee Number:
- 18
- Annual Fee Amount:
- 262 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 28/11/2025
- Last Annual Fee Paid Number:
- 17
- Last Annual Fee Paid Amount:
- 246 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|